AMEX:NHS

Stock Analysis Report

Neuberger Berman High Yield Strategies Fund

Executive Summary

Neuberger Berman High Yield Strategies Fund Inc.

Rewards


Snowflake Analysis

Share Price & News

How has Neuberger Berman High Yield Strategies Fund's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: NHS's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-2.7%

NHS

-1.1%

US Capital Markets

-2.8%

US Market


1 Year Return

-28.1%

NHS

-14.5%

US Capital Markets

-15.9%

US Market

Return vs Industry: NHS underperformed the US Capital Markets industry which returned -14.5% over the past year.

Return vs Market: NHS underperformed the US Market which returned -15.9% over the past year.


Shareholder returns

NHSIndustryMarket
7 Day-2.7%-1.1%-2.8%
30 Day-29.1%-17.6%-18.8%
90 Day-32.4%-24.9%-24.0%
1 Year-21.2%-28.1%-12.8%-14.5%-14.2%-15.9%
3 Year-11.4%-30.1%6.7%0.6%9.9%2.8%
5 Year-0.9%-34.3%30.7%18.4%27.2%13.3%

Price Volatility Vs. Market

How volatile is Neuberger Berman High Yield Strategies Fund's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Neuberger Berman High Yield Strategies Fund undervalued compared to its fair value and its price relative to the market?

34.1%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: NHS ($8.3) is trading below our estimate of fair value ($12.6)

Significantly Below Fair Value: NHS is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: NHS is good value based on its PE Ratio (7.2x) compared to the Capital Markets industry average (33.7x).

PE vs Market: NHS is good value based on its PE Ratio (7.2x) compared to the US market (12.2x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate NHS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: NHS is good value based on its PB Ratio (0.7x) compared to the US Capital Markets industry average (7.7x).

Future Growth

How is Neuberger Berman High Yield Strategies Fund forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

5.3%

Forecasted Diversified Financials industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Neuberger Berman High Yield Strategies Fund has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has Neuberger Berman High Yield Strategies Fund performed over the past 5 years?

18.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: NHS has a large one-off gain of $8.6M impacting its October 31 2019 financial results.

Growing Profit Margin: NHS became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: NHS's earnings have grown by 18.2% per year over the past 5 years.

Accelerating Growth: NHS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: NHS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Capital Markets industry (9.7%).


Return on Equity

High ROE: NHS's Return on Equity (9.1%) is considered low.

Financial Health

How is Neuberger Berman High Yield Strategies Fund's financial position? (This company is analysed differently as a bank or financial institution)


Financial Position Analysis


Debt to Equity History and Analysis


Balance Sheet

Inventory Level: NHS has a low level of unsold assets or inventory.

Debt Coverage by Assets: NHS's debt is not covered by short term assets (assets are 0.1x debt).


Financial Institutions Analysis

Asset Level: NHS's level of assets compared to its equity is low.

Allowance for Bad Loans: Insufficient data to determine if NHS has a sufficient allowance for bad loans.

Low Risk Liabilities: NHS reports no customer deposits, loans are made up entirely of externally borrowed funds.

Loan Level: Insufficient data to determine if NHS has an acceptable proportion of non-loan assets held.

Low Risk Deposits: NHS has advanced significantly more loans than the customer deposits it holds.

Level of Bad Loans: Insufficient data to determine if NHS has an appropriate level of bad loans.

Dividend

What is Neuberger Berman High Yield Strategies Fund's current dividend yield, its reliability and sustainability?

13.08%

Current Dividend Yield


Upcoming Dividend Payment


Dividend Yield vs Market

Notable Dividend: NHS's dividend (13.08%) is higher than the bottom 25% of dividend payers in the US market (2.07%).

High Dividend: NHS's dividend (13.08%) is in the top 25% of dividend payers in the US market (5.82%)


Stability and Growth of Payments

Stable Dividend: NHS's dividends per share have been stable in the past 10 years.

Growing Dividend: NHS's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: At its current payout ratio (81.4%), NHS's payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.

Management

How experienced are the management team and are they aligned to shareholders interests?

13.3yrs

Average board tenure


CEO

Robert Conti (63yo)

no data

Tenure

Mr. Robert John Conti, also known as Bobby, has been the Chief Executive Officer and President of Neuberger Berman BD LLC since 2008. Mr. Conti has been a Managing Director at Neuberger Berman LLC since 20 ...


Board Members

NamePositionTenureCompensationOwnership
Robert Conti
Chief Executive Officerno datano datano data
Joseph Amato
Director11.25yrsno datano data
Howard Mileaf
Independent Director14yrsUS$16.86kno data
Martha Goss
Independent Director12.83yrsUS$16.42kno data
Tom Seip
Non-Executive Chairman11.33yrsUS$20.54kno data
Candace Straight
Independent Director14yrsUS$17.58kno data
Peter Trapp
Independent Director14yrsUS$18.02kno data
Faith Colish
Independent Director14yrsUS$17.58kno data
George Morriss
Independent Director13.25yrsUS$17.58k0.020% $31.7k
Michael Knetter
Independent Director13.25yrsUS$17.58kno data

13.3yrs

Average Tenure

70yo

Average Age

Experienced Board: NHS's board of directors are seasoned and experienced ( 13.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Neuberger Berman High Yield Strategies Fund Inc.'s company bio, employee growth, exchange listings and data sources


Key Information


Location

  • Neuberger Berman High Yield Strategies Fund Inc.
  • 1290 Avenue of the Americas
  • New York City
  • New York
  • 10104
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NHSAMEX (NYSE MKT LLC)YesCommon SharesUSUSDJul 2003

Biography

Neuberger Berman High Yield Strategies Fund Inc. is a closed-ended fixed income mutual fund launched by Neuberger Berman LLC. The fund is managed by Neuberger Berman Investment Advisers LLC. It invests in fixed income markets across the globe. The fund typically invests in high yield debt securities of various sectors, such as auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution. It was formerly known as Neuberger Berman High Yield Strategies Fund. Neuberger Berman High Yield Strategies Fund Inc. was formed on July 28, 2003 and is domiciled in the United States. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/04/05 05:14
End of Day Share Price2020/04/03 00:00
Earnings2019/10/31
Annual Earnings2019/10/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.